Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.
Camille LaurentMaria FloresLoïc ChartierSarah HuetChristopher R BolenJeffrey M VenstromCatherine Chassagne-ClémentPeggy Dartigues-CuilléresFréderic CharlotteBruno TessonGilles SallesFranck MorschhauserLuc XerriPublished in: British journal of haematology (2023)